Chromosome copy number variation and breast cancer risk

Cytogenetic and Genome Research

Volumn 123, Issue 1-4, 2009, Pages 183-187

  Tchatchou, S ^b   Burwinkel, B ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RISK; FAMILIAL CANCER; GENE; GENE COPY NUMBER VARIATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GSTM1 GENE; GSTT1 GENE; HUMAN; MTUS1 GENE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CHROMOSOMES; GENE DOSAGE; GENOME; HUMANS; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 62549134474     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184707     Document Type: Review

References (58)

1. Balmain A, Gray J, Ponder BA: The genetics and genomics of cancer. Nat Genet 33:238-244 (2003).
2. Boyle P, Ferlay J: Cancer incidence and mortality in Europe. 2004. Ann Oncol 16:481-488 (2005).
3. Buffone A, Capalbo C, Ricevuto E, Sidoni T, Ottini L, et al: Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families. Breast Cancer Res Treat 106:289-296 (2007).
4. Cai WW, Mao JH, Chow CW, Damani S, Balmain A, Bradley A: Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol 20:393-396 (2002).
5. Casilli F, Tournier I, Sinilnikova OM, Coulet F, Soubrier F, et al: The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 43:e49 (2006).
6. Chaib H, MacDonald JW, Vessella RL, Washburn JG, Quinn JE, et al: Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors. Genes Chromosomes Cancer 37:306-313 (2003).
7. Charafe-Jauffret E, Moulin JF, Ginestier C, Bechlian D, Conte N, et al: Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells. Int J Oncol 21:989-996 (2002).
8. Chen J, Kim YC, Jung YC, Xuan Z, Dworkin G, et al: Scanning the human genome at kilobase resolution. Genome Res 18:751-762 (2008).
9. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093 (2007).
10. Engert S, Wappenschmidt B, Betz B, Kast K, Kutsche M, et al: MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Hum Mutat 29:948-958 (2008).
11. Feuk L, Carson AR, Scherer SW: Structural variation in the human genome. Nat Rev Genet 7:85-97 (2006).
12. Frank B, Bermejo JL, Hemminki K, Sutter C, Wappenschmidt B, et al: Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis 28:1442-1445 (2007).
13. Gad S, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, et al: Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21:6841-6847 (2002a).
14. Gad S, Klinger M, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, et al: Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families. J Med Genet 39:817-821 (2002b).
15. Gutierrez-Enriquez S, de la Hoya M, Martinez-Bouzas C, Sanchez de Abajo A, Ramon y Cajal T, et al: Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat 103:103-107 (2007).
16. Hartmann C, John AL, Klaes R, Hofmann W, Bielen R, et al: Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 24:534 (2004).
17. Hayes JD, Pulford DJ: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600 (1995).
18. Hemminki K, Granstrom C: Familial breast cancer: scope for more susceptibility genes? Breast Cancer Res Treat 82:17-22 (2003).
19. Hemminki K, Granstrom C, Czene K: Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden. Int J Cancer 100:214-219 (2002).
20. Hinds DA, Kloek AP, Jen M, Chen X, Frazer KA: Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat Genet 38:82-85 (2006).
21. Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, et al: Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63:1449-1453 (2003).
22. Human Genome Structural Variation Working Group, Eichler EE, Nickerson DA, Altshuler D, Bowcock AM, et al: Completing the map of human genetic variation. Nature 447:161-165 (2007).
23. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870-874 (2007).
24. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C: Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic, and clinical aspects. Pharmacol Therap 116:496-526 (2007).
25. Johansson L, Lundquist E, Bertilsson L, Dahl ML, Sjoqvist F, Ingelmann-Sundberg M: Inherited amplification of an active gene in cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci USA 90:11825-11829 (1993).
26. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, et al: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821 (1992).
27. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, et al: Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res 57:5469-5474 (1997).
28. Key TJ, Verkasalo PK, Banks E: Epidemiology of breast cancer. Lancet Oncol 2:133-140 (2001).
29. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al: Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85 (2000).
30. Meindl A: Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97:472-480 (2002).
31. Miki K, Eddy EM: Single amino acids determine specificity of binding of protein kinase A regulatory subunits by protein kinase A anchoring proteins. J Biol Chem 274:29057-29062 (1999).
32. Montagna M, Dalla Palma M, Menin C, Agata S, De Nicolo A, et al: Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12:1055-1061 (2003).
33. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, et al: A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 65:6071-6079 (2005).
34. Narod S: What options for treatment of hereditary breast cancer? Lancet 359:1451-1452 (2002).
35. Narod SA, Boyd J: Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr Opin Obstet Gynecol 14:19-26 (2002).
36. Nathanson KL, Wooster R, Weber BL: Breast cancer genetics: what we know and what we need. Nat Med 7:552-556 (2001).
37. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (2005).
38. Perry GH, Ben-Dor A, Tsalenko A, Sampas N, Rodriguez-Revenga L, et al: The fine-scale and complex architecture of human copy number variation. Am J Hum Genet 82:685-695 (2008).
39. Peto J, Collins N, Barfoot R, Seal S, Warren W, et al: Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943-949 (1999).
40. Pils D, Horak P, Gleiss A, Sax C, Fabjani G, et al: Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer 104:2417-2429 (2005).
41. Pineau P, Nagai H, Prigent S, Wei Y, Gyapay G, et al: Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma. Oncogene 18:3127-3134 (1999).
42. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, et al: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211 (1998).
43. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al: Global variation in copy number in the human genome. Nature 444:444-454 (2006).
44. Reiter R, Wellstein A, Riegel AT: An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer. J Biol Chem 276:39736-39741 (2001).
45. Roodi N, Dupont WD, Moore JH, Parl FF: Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk. Cancer Res 64:1233-1236 (2004).
46. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57 (2002).
47. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al: Large-scale copy number polymorphism in the human genome. Science 305:525-528 (2004).
48. Seibold S, Rudroff C, Weber M, Galle J, Wanner C, Marx M: Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J 17:1180-1182 (2003).
49. Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, et al: Segmental duplications and copy number variation in the human genome. Am J Hum Genet 77:78-88 (2005).
50. Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmöller J, et al: Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 10:557-565 (2000).
51. Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2 . Cell 108:171-182 (2002).
52. Vogl FD, Taioli E, Maugard C, Zheng W, Pinto LF, et al: Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 13:1473-1479 (2004).
53. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, et al: Spectrum of mutations in BRCA1 , BRCA2, CHEK2 and TP53 in families at high risk of breast cancer. JAMA 295:1379-1388 (2006).
54. Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, et al: Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 16:1615-1620 (2007).
55. Wilson P, Cuthbert A, Marsh A, Arnold J, Flanagan J, et al: Transfer of chromosome 8 into two breast cancer cell lines: total exclusion of three regions indicates location of putative in vitro growth suppressor genes. Cancer Genet Cytogenet 143:100-112 (2003).
56. Wirtenberger M, Hemminki K, Burwinkel B: Identification of frequent chromosome copy number polymorphisms by use of high-resolution single-nucleotide-polymorphism arrays. Am J Hum Genet 78:520-522 (2006).
57. Wooster R, Weber BL: Breast and ovarian cancer. N Engl J Med 348:2339-2347 (2003).
58. Yokota T, Yoshimoto M, Akiyama F, Sakamoto G, Kasumi F, et al: Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1. Cancer 85:447-452 (1999).